COMMUNIQUÉS West-GlobeNewswire

-
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
19/12/2024 -
CorMedix Inc. Added to Nasdaq Biotechnology Index
19/12/2024 -
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality
19/12/2024 -
HWH International Inc. Provides Updates on Hapi Cafe Business
19/12/2024 -
Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
19/12/2024 -
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
19/12/2024 -
TOMI Environmental Stands Ready to Protect Public Health Amidst H5N1 Bird Flu California State Emergency
19/12/2024 -
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
19/12/2024 -
Aphaia Pharma to Participate in Panel Discussion at the 1st Annual BioPharma Obesity Innovation Forum in San Francisco
19/12/2024 -
Marker Therapeutics Announces $16.1 Million Private Placement
19/12/2024 -
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
19/12/2024 -
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer
19/12/2024 -
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
18/12/2024 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/12/2024 -
Amwell CFO Mark Hirschhorn Expands Leadership Role
18/12/2024 -
RemoniHealth Completes 80,000 Remote Monitoring Encounters for Chronic Retina Diseases
18/12/2024 -
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
18/12/2024 -
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
18/12/2024 -
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
18/12/2024
Pages